Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242085 · ClinicalTrials.gov registry record · Phase 3
Preoperative Alignment of Total Knee Replacement
A Phase 3 study, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- Phase 3
- Development phase
- 64
- Enrollment target
NCT01242085: Completed Phase 3 study, sponsored by VA Palo Alto Health Care System.
NCT01242085 is a Phase 3 study that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 64 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242085, a Phase 3 study, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 64 participants
- Enrollment target
Study Summary
The hypothesis of this study is that total knee alignment will be improved by preoperative planning from CT scans and the production of custom instruments compared to the use of standard instruments.
Primary Outcome
the mean knee mechanical axis was determined from 3D CT data - negative value designates varus alignment
Interventions
- PROCEDURE control group
- PROCEDURE trumatch group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
What the finished NCT01242085 record still lists
NCT01242085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which control group is the first listed.
NCT01242085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01242085 about?
NCT01242085 is a clinical study titled "Preoperative Alignment of Total Knee Replacement". The hypothesis of this study is that total knee alignment will be improved by preoperative planning from CT scans and the production of custom instruments compared to the use of standard instruments.
What is the current status of trial NCT01242085?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2010-11. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01242085?
The interventions under investigation include: control group (PROCEDURE), trumatch group (PROCEDURE).
Who is sponsoring clinical trial NCT01242085?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01242085's enrollment target sits among peer trials
64 1799th of 2000 higher than 201 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia